Maria Veiga-da-Cunha Selected Research

Flavin-Adenine Dinucleotide (FAD)

11/2004

A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Veiga-da-Cunha Research Topics

Disease

6	Neutropenia 01/2022 - 01/2019
4	2-Hydroxyglutaricaciduria 01/2020 - 11/2004
3	Glycogen Storage Disease (Glycogenosis) 07/2021 - 01/2020
2	Infections 01/2022 - 01/2021
2	Glycogen Storage Disease IB 07/2021 - 01/2020
2	Neoplasms (Cancer) 01/2017 - 09/2009
1	Crohn Disease (Crohn's Disease) 07/2021
1	Enterocolitis 07/2021
1	Short chain Acyl CoA dehydrogenase deficiency 01/2021
1	Eczema 01/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Rare Diseases (Rare Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 07/2015
1	Leukoencephalopathies 05/2013
1	Schizophrenia (Dementia Praecox) 03/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2012
1	Mason-Type Diabetes 04/2005

Drug/Important Bio-Agent (IBA)

3	empagliflozinIBA 01/2022 - 01/2020
3	1,5-anhydroglucitol-6-phosphateIBA 01/2022 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2019
3	EnzymesIBA 01/2020 - 09/2009
3	Oxidoreductases (Dehydrogenase)IBA 01/2015 - 11/2004
2	Glucose-6-PhosphateIBA 01/2022 - 01/2019
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
2	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2004
1	1,5-anhydroglucitolIBA 01/2022
1	HexokinaseIBA 01/2022
1	polyolIBA 01/2022
1	dapagliflozinIBA 12/2021
1	SugarsIBA 01/2021
1	glucose-1,6-bisphosphateIBA 01/2021
1	ethylmalonic acid (ethylmalonate)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	PhosphoglucomutaseIBA 01/2021
1	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	NAD (NADH)IBA 01/2020
1	NADP (NADPH)IBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	nitrilaseIBA 01/2017
1	phosphorylethanolamine (phosphoethanolamine)IBA 03/2012
1	omega-amidaseIBA 09/2009
1	Transaminases (Aminotransferases)IBA 09/2009
1	Glutamine (L-Glutamine)FDA Link 09/2009
1	GlucokinaseIBA 04/2005
1	AcidsIBA 11/2004
1	Flavin-Adenine Dinucleotide (FAD)IBA 11/2004
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 11/2004

Therapy/Procedure

1	Off-Label Use 01/2020